{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T12:46:31Z","timestamp":1772196391060,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.vaccine.2010.12.117","type":"journal-article","created":{"date-parts":[[2011,1,9]],"date-time":"2011-01-09T09:11:33Z","timestamp":1294564293000},"page":"1754-1761","source":"Crossref","is-referenced-by-count":13,"title":["Intranasal vaccination with pneumococcal surface protein A plus poly(I:C) protects against secondary pneumococcal pneumonia in mice"],"prefix":"10.1016","volume":"29","author":[{"given":"Hirokazu","family":"Ezoe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiro","family":"Akeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenyu","family":"Piao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiki","family":"Aoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohei","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Tanimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken J.","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Oishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.12.117_bib0005","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.amjmed.2007.10.040","article-title":"Complications of viral influenza","volume":"121","author":"Rothberg","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.vaccine.2010.12.117_bib0010","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1086\/591708","article-title":"Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness","volume":"198","author":"Morens","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.12.117_bib0015","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1056\/NEJMc0908216","article-title":"Bacterial pathogens and death during the 1918 influenza pandemic","volume":"361","author":"Chien","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2010.12.117_bib0020","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1001\/jama.2009.1583","article-title":"Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California","volume":"302","author":"Louie","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2010.12.117_bib0025","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1056\/NEJMoa0904252","article-title":"Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico","volume":"361","author":"Perez-Padilla","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2010.12.117_bib0185","doi-asserted-by":"crossref","first-page":"251","DOI":"10.7883\/yoken.63.251","article-title":"Impact of pandemic influenza (H1N1) virus-associated community-acquired pneumonia among adults in a tertiary hospital in Thailand","volume":"63","author":"Champunot","year":"2010","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.12.117_bib0190","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1164\/201001-0037OC","article-title":"Pandemic 2009 influenza A in Argentina: a study of 337 patients on mechanical ventilation","volume":"182","author":"Estenssoro","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2010.12.117_bib0040","first-page":"913","article-title":"2009 Pandemic influenza A (H1N1) virus infections\u2014Chicago, Illinois, April\u2013July 2009","volume":"58","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2010.12.117_bib0045","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMoa035060","article-title":"A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection","volume":"349","author":"Klugman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2010.12.117_bib0050","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0140-6736(05)71876-6","article-title":"Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial","volume":"365","author":"Cutts","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2010.12.117_bib0055","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1056\/NEJM199111213252101","article-title":"The protective efficacy of polyvalent pneumococcal polysaccharide vaccine","volume":"325","author":"Shapiro","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2010.12.117_bib0060","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/mpat.1996.0038","article-title":"Protection of mice against fatal pneumococcal challenge by immunization with pneumococcal surface adhesin A (PsaA)","volume":"21","author":"Talkington","year":"1996","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2010.12.117_bib0065","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.1128\/IAI.69.10.5997-6003.2001","article-title":"Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA","volume":"69","author":"Ogunniyi","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.12.117_bib0070","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.1128\/IAI.69.11.6718-6724.2001","article-title":"Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection","volume":"69","author":"Arulanandam","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.12.117_bib0075","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1128\/CVI.00395-08","article-title":"Characterization of protective mucosal and systemic immune responses elicited by pneumococcal surface protein PspA and PspC nasal vaccines against a respiratory pneumococcal challenge in mice","volume":"16","author":"Ferreira","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2010.12.117_bib0080","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1128\/CMR.11.4.645","article-title":"Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA)","volume":"11","author":"Briles","year":"1998","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2010.12.117_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2005.09.026","article-title":"Unveiling molecular mechanisms of pneumococcal surface protein A interactions with antibodies and lactoferrin","volume":"367","author":"Jedrzejas","year":"2006","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.vaccine.2010.12.117_bib0090","doi-asserted-by":"crossref","first-page":"33121","DOI":"10.1074\/jbc.M103304200","article-title":"Characterization of selected strains of pneumococcal surface protein A","volume":"276","author":"Jedrzejas","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2010.12.117_bib0095","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S0264-410X(99)00530-7","article-title":"Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules","volume":"18","author":"Nabors","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.12.117_bib0100","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1128\/IAI.72.1.114-122.2004","article-title":"Effects of PspA and antibodies to PspA on activation and deposition of complement on the pneumococcal surface","volume":"72","author":"Ren","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.12.117_bib0105","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.micpath.2007.09.007","article-title":"Vaccine-induced human antibodies to PspA augment complement C3 deposition on Streptococcus pneumoniae","volume":"44","author":"Ochs","year":"2008","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2010.12.117_bib0110","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1086\/317602","article-title":"Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA","volume":"182","author":"Briles","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.12.117_bib0115","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1016\/j.vaccine.2009.03.055","article-title":"Intranasal immunization with a mixture of PspA and a Toll-like receptor agonist induces specific antibodies and enhances bacterial clearance in the airways of mice","volume":"27","author":"Oma","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.12.117_bib0120","doi-asserted-by":"crossref","first-page":"683","DOI":"10.4049\/jimmunol.180.2.683","article-title":"Cutting edge: cooperation of IPS-1- and TRIF-dependent pathways in poly IC-enhanced antibody production and cytotoxic T cell responses","volume":"180","author":"Kumar","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.12.117_bib0125","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1128\/IAI.68.2.796-800.2000","article-title":"Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae","volume":"68","author":"Briles","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.12.117_bib0130","doi-asserted-by":"crossref","first-page":"8894","DOI":"10.1128\/JVI.79.14.8894-8903.2005","article-title":"Pathogenesis of human metapneumovirus lung infection in BALB\/c mice and cotton rats","volume":"79","author":"Hamelin","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.12.117_bib0135","first-page":"1385","article-title":"Pulmonary lesions in primary respiratory syncytial virus infection, reinfection, and vaccine-enhanced disease in the cotton rat (Sigmodon hispidus)","volume":"79","author":"Prince","year":"1999","journal-title":"Lab Invest"},{"key":"10.1016\/j.vaccine.2010.12.117_bib0140","doi-asserted-by":"crossref","first-page":"7603","DOI":"10.4049\/jimmunol.172.12.7603","article-title":"IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection","volume":"172","author":"van der Sluijs","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.12.117_bib0145","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nm1765","article-title":"Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection","volume":"14","author":"Sun","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2010.12.117_bib0150","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1172\/JCI35412","article-title":"Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice","volume":"119","author":"Shahangian","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2010.12.117_bib0155","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1084\/jem.20070891","article-title":"Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection","volume":"205","author":"Didierlaurent","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2010.12.117_bib0160","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1086\/600871","article-title":"Pneumococcal surface protein A contributes to secondary Streptococcus pneumoniae infection after influenza virus infection","volume":"200","author":"King","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.12.117_bib0165","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1086\/521304","article-title":"Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine","volume":"196","author":"Ichinohe","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.12.117_bib0170","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/BF01709367","article-title":"Results of a double-blind placebo-controlled study of the double-stranded RNA drug polyI:polyC12U in the treatment of HIV infection","volume":"15","author":"Thompson","year":"1996","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2010.12.117_bib0175","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1128\/CVI.00400-07","article-title":"Optimized immune response elicited by a DNA vaccine expressing pneumococcal surface protein A is characterized by a balanced immunoglobulin G1 (IgG1)\/IgG2a ration and proinflammatory cytokine production","volume":"15","author":"Ferreira","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2010.12.117_bib0180","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.4049\/jimmunol.1000831","article-title":"Secretory-IgA antibodies play an important role in the immunity to Streptococcus pneumoniae","volume":"185","author":"Fukuyama","year":"2010","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10019043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10019043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T20:07:16Z","timestamp":1685909236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10019043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0264410X10019043"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.12.117","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}